-
Addiction medicine treatment utilization by race/ethnicity among adolescents with substance use problem before versus during the COVID-19 pandemic.
Palzes VA, Chi FW, Metz VE, Asyyed A, Ridout KK, Campbell CI. Addiction medicine treatment utilization by race/ethnicity among adolescents with substance use problem before versus during the COVID-19 pandemic. Journal of Adolescent Health 2024;74(6):1260-1263.
-
Program director reports of COVID-19 lockdown-driven service changes in community-based STI clinics and syringe services programs in the southeastern U.S.
Hatch MA, Laschober TC, Ertl MM, Paschen-Wolff MM, Norman G, Wright L, Tross S. Program director reports of COVID-19 lockdown-driven service changes in community-based STI clinics and syringe services programs in the southeastern U.S. AIDS Education and Prevention 2024;36(2):129-140.
-
Empirically contrasting urine drug screening-based opioid use disorder treatment outcome definitions.
Brandt L, Odom GJ, Hu M, Castro C, Balise RR, CTN-0094 Team. Empirically contrasting urine drug screening-based opioid use disorder treatment outcome definitions. Addiction 2024119(7):1289-1300.
-
Rapid initiation of injection naltrexone for opioid use disorder: A stepped-wedge cluster randomized clinical trial.
Shulman M, Greiner MG, Tafessu HM, Opara O, Ohrtman K, Potter K, Hefner K, Jelstrom E, Rosenthal RN, Wenzel K, Fishman M, Rotrosen J, Ghitza U, Nunes EV, Bisaga A. Rapid initiation of injection naltrexone for opioid use disorder: A stepped-wedge cluster randomized clinical trial. JAMA Network Open 2024;7(5):e249744.
-
Exemplar Hospital Initiation Trial to Enhance Treatment Engagement (EXHIT ENTRE): Protocol for CTN-0098B A randomized implementation study to support hospitals in caring for patients with opioid use disorder.
Bart G, Korthuis PT, Donohue JM, Hagedorn HJ, Gustafson DH, Bazzi AR, Enns E, McNeely J, Ghitza UE, Magane KM, Baukol P, Vena A, Harris J, Voronca D, Saitz R. Exemplar Hospital Initiation Trial to Enhance Treatment Engagement (EXHIT ENTRE): Protocol for CTN-0098B A randomized implementation study to support hospitals in caring for patients with opioid use disorder. Addiction Science & Clinical Practice 2024;19:29.
-
Characterization of peer support services for substance use disorders in 11 US emergency departments in 2020: Findings from a NIDA Clinical Trials Network site selection process.
Jennings LK, Lander L, Lawdahl T, McClure EA, Moreland A, McCauley JL, Haynes L, Matheson T, Jones R, Robey TE, Kawasaki S, Moschella P, Raheemullah A, Miller S, Gregovich G, Waltman D, Brady KT, Barth KS. Characterization of peer support services for substance use disorders in 11 US emergency departments in 2020: Findings from a NIDA Clinical Trials Network site selection process. Addiction Science & Clinical Practice 2024;19:26.
-
Medication-based treatment among rural, primary care patients diagnosed with opioid use disorder and alcohol use disorder.
Kan E, Baldwin L, Mooney LJ, Saxon AJ, Zhu Y, Hser Y. Medication-based treatment among rural, primary care patients diagnosed with opioid use disorder and alcohol use disorder. Journal of Substance Use and Addiction Treatment 2024;164:209339.
-
National Institute on Drug Abuse Clinical Trials Network meeting report: Managing patients exposed to xylazine-adulterated opioids in emergency, hospital and addiction care settings.
Perrone J, Haroz R, D'Orazio J, Gianotti G, Love J, Salzman M, Lowenstein M, Thakrar A, Klipp S, Rae L, Reed MK, Sisco E, Wightman R, Nelson LS. National Institute on Drug Abuse Clinical Trials Network meeting report: Managing patients exposed to xylazine-adulterated opioids in emergency, hospital and addiction care settings. Annals of Emergency Medicine 2024;84(1):20-28.
-
Protocol for harmonization of randomized trials testing the addition of behavioral therapy to buprenorphine for opioid use disorder.
McHugh RK, Bailey AJ, Weiss RD, Fitzmaurice GM. Protocol for harmonization of randomized trials testing the addition of behavioral therapy to buprenorphine for opioid use disorder. Drug and Alcohol Dependence Reports 2024;11:100226.
-
Implementing a pharmacist-integrated collaborative model of medication treatment for opioid use disorder in primary care: Study design and methodological considerations.
McLeman B, Gauthier P, Lester LS, Homsted F, Gardner V III, Moore SK, Jourdrey PJ, Saldana L, Cochran G, Harris JP, Hefner K, Chongsi E, Kramer K, Vena A, Ottesen RA, Gallant T, Boggis JS, Rao D, Page M, Cox N, Iandiorio M, Ambaah E, Ghitza U, Fiellin DA, Marsch LA. Implementing a pharmacist-integrated collaborative model of medication treatment for opioid use disorder in primary care: Study design and methodological considerations. Addiction Science & Clinical Practice 2024;19:18.